DexCom
DXCM
YETI Holdings
YETI
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Collegium Pharmaceutical
COLL
Lantheus
LNTH
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -51.66%9.28M | 112.14%684K | -89.61%-1.86M | -54.80%14.6M | -91.64%2.03M | 1,267.50%19.19M | -255.44%-5.63M | -132.78%-982K | 661.21%32.3M | 5,735.34%24.28M |
Net income from continuing operations | 144.37%2.21M | -75.05%1.71M | -210.70%-393K | 190.55%3.11M | 83.64%887K | -458.99%-4.97M | 695.90%6.84M | 108.55%355K | 84.04%-3.43M | 106.90%483K |
Depreciation and amortization | -27.62%1.55M | -9.96%1.91M | -12.60%1.91M | -5.25%8.54M | -5.91%2.1M | -5.94%2.14M | -6.24%2.12M | -2.89%2.18M | -5.67%9.01M | -2.06%2.23M |
Deferred tax | -141.60%-52K | 113.56%8K | 139.13%9K | -2,600.00%-108K | -202.00%-151K | 331.03%125K | -310.71%-59K | -109.09%-23K | -100.29%-4K | -103.89%-50K |
Other non cash items | -5.42%384K | -16.16%441K | 22.81%560K | 25.42%1.94M | 31.44%556K | 9.14%406K | -3.49%526K | 117.14%456K | 85.63%1.55M | 100.47%423K |
Change In working capital | -107.58%-1.2M | 55.61%-8.67M | -11.21%-9.57M | -436.10%-19.19M | -142.14%-6.85M | 304.27%15.79M | -899.23%-19.53M | -908.79%-8.61M | 368.15%5.71M | 644.04%16.25M |
-Change in receivables | -52.16%9.81M | 36.58%-9.16M | 50.96%-2.39M | -28.23%-2.75M | -130.59%-3.93M | 208.44%20.51M | -995.17%-14.45M | -312.20%-4.87M | 64.16%-2.14M | 300.25%12.86M |
-Change in prepaid assets | -1,464.72%-5.84M | 60.23%-2.58M | 58.07%-408K | -26.65%-7.33M | 90.42%-291K | -6.55%428K | -190.91%-6.49M | 0.31%-973K | -609.42%-5.79M | -326.54%-3.04M |
-Change in payables and accrued expense | 229.48%3.82M | 56.76%-4.47M | 32.41%2.01M | -920.56%-2.04M | 281.94%5.61M | -66.44%1.16M | -857.67%-10.33M | 202.29%1.52M | 133.79%248K | -319.97%-3.08M |
-Change in other current assets | -482.90%-3.78M | -212.14%-896K | -3,094.25%-5.56M | -172.59%-2.96M | -369.45%-2.94M | -186.65%-649K | -23.47%799K | -114.55%-174K | 5,129.49%4.08M | 343.09%1.09M |
-Change in other current liabilities | -70.45%-600K | -5.17%-366K | -69.68%-319K | 38.18%-1.29M | 14.93%-399K | -18.52%-352K | -25.18%-348K | 81.89%-188K | -31.44%-2.08M | -19.95%-469K |
-Change in other working capital | 13.22%-4.6M | -22.02%8.81M | 25.75%-2.91M | -124.82%-2.83M | -155.09%-4.9M | -177.84%-5.3M | 425.89%11.29M | -364.34%-3.92M | 129.95%11.39M | 207.68%8.89M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -51.66%9.28M | 112.14%684K | -89.61%-1.86M | -54.80%14.6M | -91.64%2.03M | 1,267.50%19.19M | -255.44%-5.63M | -132.78%-982K | 661.21%32.3M | 5,735.34%24.28M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 12.13%-4.01M | 192.07%6.84M | -17.27%-2.64M | -134.27%-28.99M | -1,285.22%-14.76M | -140.12%-4.56M | -112.43%-7.42M | -118.35%-2.25M | 1,912.71%84.6M | 102.65%1.25M |
Net PPE purchase and sale | -61.51%-4.54M | -71.67%-5.32M | 30.29%-2.02M | -33.10%-11.22M | -39.59%-2.41M | -32.72%-2.81M | -9.82%-3.1M | -64.42%-2.9M | -107.99%-8.43M | -28.73%-1.73M |
Net intangibles purchase and sale | ---- | ---- | ---- | 0.00%-150K | --0 | ---- | ---- | ---- | ---150K | --0 |
Net business purchase and sale | ---- | ---- | ---- | ---1.82M | --0 | ---- | ---- | ---- | --0 | --0 |
Net investment purchase and sale | 136.73%535K | 381.04%12.16M | -195.38%-619K | -116.95%-15.8M | -515.76%-12.35M | -98.34%226K | -106.92%-4.33M | -95.38%649K | 3,718.81%93.18M | 106.98%2.97M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 12.13%-4.01M | 192.07%6.84M | -17.27%-2.64M | -134.27%-28.99M | -1,285.22%-14.76M | -140.12%-4.56M | -112.43%-7.42M | -118.35%-2.25M | 1,912.71%84.6M | 102.65%1.25M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 43.44%-1.76M | -5.25%-401K | -318.16%-8.75M | 75.77%-5.89M | -158.68%-313K | -1,786.41%-3.1M | 97.81%-381K | 70.06%-2.09M | -339.95%-24.31M | -290.32%-121K |
Net common stock issuance | --0 | --0 | ---6.9M | 96.69%-743K | --0 | ---743K | --0 | --0 | -396.82%-22.47M | --0 |
Proceeds from stock option exercised by employees | -1.22%2.18M | -22.99%67K | -3.34%1.94M | -7.94%4.32M | -96.30%23K | 23.59%2.21M | -23.01%87K | -7.76%2.01M | 58.41%4.7M | -8.39%622K |
Net other financing activities | 13.84%-3.93M | 0.00%-468K | 7.49%-3.79M | -44.97%-9.47M | 54.78%-336K | -185.20%-4.57M | 41.50%-468K | -21.01%-4.1M | -64.68%-6.53M | -4.65%-743K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 43.44%-1.76M | -5.25%-401K | -318.16%-8.75M | 75.77%-5.89M | -158.68%-313K | -1,786.41%-3.1M | 97.81%-381K | 70.06%-2.09M | -339.95%-24.31M | -290.32%-121K |
Net cash flow | ||||||||||
Beginning cash position | -8.34%91.99M | -25.46%85.26M | -17.26%98.98M | 332.11%119.62M | 19.09%111.62M | 23.38%100.36M | 219.51%114.38M | 332.11%119.62M | -18.13%27.68M | 26.22%93.73M |
Current changes in cash | -69.50%3.52M | 152.97%7.12M | -148.80%-13.26M | -121.90%-20.28M | -151.34%-13.04M | -10.99%11.53M | -129.24%-13.44M | -164.33%-5.33M | 1,656.40%92.59M | 154.52%25.4M |
Effect of exchange rate changes | 449.43%926K | 33.73%-387K | -641.86%-466K | 43.85%-365K | -19.92%398K | 52.93%-265K | -40.05%-584K | 151.50%86K | -257.14%-650K | 4,418.18%497K |
End cash Position | -13.61%96.43M | -8.34%91.99M | -25.46%85.26M | -17.26%98.98M | -17.26%98.98M | 19.09%111.62M | 23.38%100.36M | 219.51%114.38M | 332.11%119.62M | 332.11%119.62M |
Free cash flow | -70.97%4.68M | 46.91%-4.64M | -0.03%-3.89M | -86.82%3.13M | -101.68%-379K | 1,963.58%16.12M | -1,188.78%-8.73M | -415.52%-3.88M | 12,383.16%23.72M | 2,540.48%22.55M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |